While some insurers are cutting rebates for Ozempic and similar weight-loss drugs, others are waiting to see whether the long-term benefits outweigh the risks.
![](/assets/images/cip-icon.png)
ANZIIF is the leading membership, training and professional development organisation for the insurance and finance industry in the Asia-Pacific region. We partner with a broad range of organisations and government to provide services that support professional excellence. We help enhance standards and improve community understanding of insurance and finance.
Comments
Remove Comment
Are you sure you want to delete your comment?
This cannot be undone.